Let us help you extract all information from your bioassay
What our platform can do for you
Bioassay Sciences is an internationally recognized scientific and engineering consulting firm targeted on design, support and validation of bioassays. We use a platform approach to rapid bioassay development, systems suitability, parallelism and control.
”Bioassay Sciences is targeted to serve the special needs of Bioassay Scientists globally. We work with the special needs of cell based potency assays, binding assays and animal assays to name a few.
Thomas A. LittleFounder
Say hello to your team
We work with a dedicated team of people across the globe to be able to serve your analytical needs.
Thomas A. Little
Founder + CEO
Dr. Thomas A. Little is President of Thomas A. Little Consulting (TLC) and BioAssay Sciences. He has a B.S. from Brigham Young University and a Ph.D. from Purdue University and is a former professor at San Jose State University with extensive experience in applying analytical methods to pharmaceutical, medical device, semiconductor and consumer products development and manufacturing. He has published numerous articles and books and has presented papers on the subjects of Six Sigma, analytical thinking and quality engineering. Dr. Little has trained over 15,000 engineers and scientists during his career.
Paul Deen
Director Europe
Paul leads the European operations for BAS and specializes in data driven product development through the application of statistical methods: Characterization experiments (Design of experiment/DOE), model building, robust optimization and tolerance design, measurement systems analysis, statistical process control, reliability, and six sigma methods.
Paul has a MSc Production Engineering and Logistics from Delft University of Technology and a MSc Biostatistics from University of Florida.
Adam Little
Vice President of Bioassay Development
Adam is a biostatistician, data scientist and software developer currently consulting in the biotechnology industry. His primary area of expertise is in analyzing gene and cell therapies in various stages of development.
Daniel Harding
Principal Consultant
Statistical expertise in application, training, teamwork, and leadership. Experienced in a wide range of advanced statistical methods with strong analytical capabilities and data exploration skills. Key contributor to development and validation of analytical methods. Quality by Design practitioner.
Dan has a MSc in Biostatistics from California State University-East Bay.
Mark Olstad
Director of Process Characterization and Control
Support pharmaceutical process characterization and control activities with a focus on CMC strategy and execution. Apply risk-based methodologies, statistics, DOEs, and data-driven analysis to define operating ranges, optimize processes, and establish effective control plans that ensure product quality, process robustness, and regulatory compliance. Expertise with JMP, statistical methods, and data science. Chemical engineering and semiconductor background.
John Little
Vice President Quality Assurance
Years of experience
30
Clients served
100
+
Bioassays Developed
450
+
Regulatory Approvals
275
+